Cargando…

The Adult Film Industry: Time to Regulate?

The industry is putting the health of its employees, adult film perfomers, at risk by insisting that they work without condoms.

Detalles Bibliográficos
Autores principales:	Grudzen, Corita R, Kerndt, Peter R
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2007
Materias:	Policy Forum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1892037/ https://www.ncbi.nlm.nih.gov/pubmed/17579507 http://dx.doi.org/10.1371/journal.pmed.0040126

Ejemplares similares

Government Inaction on Ratings and Government Subsidies to the US Film Industry Help Promote Youth Smoking
por: Millett, Christopher, et al.
Publicado: (2011)

Lessons on Ethical Decision Making from the Bioscience Industry
por: Mackie, Jocelyn E, et al.
Publicado: (2006)

Soft Targets: Nurses and the Pharmaceutical Industry
por: Jutel, Annemarie, et al.
Publicado: (2008)

Mandatory Disclosure of Pharmaceutical Industry-Funded Events for Health Professionals
por: Robertson, Jane, et al.
Publicado: (2009)

Clinical Trial Registration: The Differing Views of Industry, the WHO, and the Ottawa Group
por: Krleža-Jerić, Karmela
Publicado: (2005)

The Global Threat of Counterfeit Drugs: Why Industry and Governments Must Communicate the Dangers
por: Cockburn, Robert, et al.
Publicado: (2005)

Soda and Tobacco Industry Corporate Social Responsibility Campaigns: How Do They Compare?
por: Dorfman, Lori, et al.
Publicado: (2012)

Industry Use of Evidence to Influence Alcohol Policy: A Case Study of Submissions to the 2008 Scottish Government Consultation
por: McCambridge, Jim, et al.
Publicado: (2013)

A Public Health Framework for Legalized Retail Marijuana Based on the US Experience: Avoiding a New Tobacco Industry
por: Barry, Rachel Ann, et al.
Publicado: (2016)

Time to Regenerate: Ecosystems and Health Promotion
por: Butler, Colin D, et al.
Publicado: (2006)

Accelerating the Uptake and Timing of Antiretroviral Therapy Initiation in Sub-Saharan Africa: An Operations Research Agenda
por: Rosen, Sydney, et al.
Publicado: (2016)

XDR-TB in South Africa: No Time for Denial or Complacency
por: Singh, Jerome Amir, et al.
Publicado: (2007)

Blindness in Childhood in Developing Countries: Time for a Reassessment?
por: Gogate, Parikshit, et al.
Publicado: (2009)

Regulating the Market in Human Research Participants
por: Lemmens, Trudo, et al.
Publicado: (2006)

The Unintended Consequences of Clinical Trials Regulations
por: McMahon, Alex D., et al.
Publicado: (2009)

Randomized Trials to Optimize Treatment of Multidrug-Resistant Tuberculosis: The time for action is now
por: Mitnick, Carole D, et al.
Publicado: (2007)

The New International Health Regulations and the Federalism Dilemma
por: Wilson, Kumanan, et al.
Publicado: (2006)

When Children Become Adults: Should Biobanks Re-Contact?
por: Giesbertz, Noor A. A., et al.
Publicado: (2016)

Suicide Prevention for Older Adults in Residential Communities: Implications for Policy and Practice
por: Podgorski, Carol A., et al.
Publicado: (2010)

Policy Coherence in US Tobacco Control: Beyond FDA Regulation
por: Yang, Joshua S., et al.
Publicado: (2009)

Strengthening Medical Product Regulation in Low- and Middle-Income Countries
por: Preston, Charles, et al.
Publicado: (2012)

Evolution of drug regulations and regulatory innovation for anticancer drugs in China
por: Liu, Yang, et al.
Publicado: (2022)

Will Spam Overwhelm Our Defenses? Evaluating Offerings for Drugs and Natural Health Products
por: Gernburd, Peter, et al.
Publicado: (2007)

Assessing Antimalarial Efficacy in a Time of Change to Artemisinin-Based Combination Therapies: The Role of Médecins Sans Frontières
por: Guthmann, Jean-Paul, et al.
Publicado: (2008)

Searching for Public Health Law’s Sweet Spot: The Regulation of Sugar-Sweetened Beverages
por: Studdert, David M., et al.
Publicado: (2015)

A Call for Action: The Application of the International Health Regulations to the Global Threat of Antimicrobial Resistance
por: Wernli, Didier, et al.
Publicado: (2011)

Dengue Vaccines Regulatory Pathways: A Report on Two Meetings with Regulators of Developing Countries
por: Mahoney, Richard, et al.
Publicado: (2011)

Who Should Pay for Global Health, and How Much?
por: Carrasco, Luis R., et al.
Publicado: (2013)

Grand Challenges in Global Health: Ethical, Social, and Cultural Issues Based on Key Informant Perspectives
por: Berndtson, Kathryn, et al.
Publicado: (2007)

A National Health Insurance Program for the United States
por: McCanne, Don R
Publicado: (2004)

Do We Need to Put Society First? The Potential for Tragedy in Antimicrobial Resistance
por: Foster, Kevin R, et al.
Publicado: (2006)

Ghostwriting at Elite Academic Medical Centers in the United States
por: Lacasse, Jeffrey R., et al.
Publicado: (2010)

Informing the 2011 UN Session on Noncommunicable Diseases: Applying Lessons from the AIDS Response
por: Lamptey, Peter, et al.
Publicado: (2011)

HIV prevention for the next decade: Appropriate, person-centred, prioritised, effective, combination prevention
por: Godfrey-Faussett, Peter, et al.
Publicado: (2022)

Treatment of latent infection to achieve tuberculosis elimination in low-incidence countries
por: Campbell, Jonathon R., et al.
Publicado: (2019)

Antimicrobial resistance in Neisseria gonorrhoeae: Global surveillance and a call for international collaborative action
por: Wi, Teodora, et al.
Publicado: (2017)

Harnessing Poverty Alleviation to Reduce the Stigma of HIV in Sub-Saharan Africa
por: Tsai, Alexander C., et al.
Publicado: (2013)

Water Supply and Health
por: Hunter, Paul R., et al.
Publicado: (2010)

The Imperative to Share Clinical Study Reports: Recommendations from the Tamiflu Experience
por: Doshi, Peter, et al.
Publicado: (2012)

Training and HIV-Treatment Scale-Up: Establishing an Implementation Research Agenda
por: McCarthy, Elizabeth A, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_m1rh69ha9n6d7irpdq2aq5js6t